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ABSTRACT
We have obtained and studied a 105,000-g pellet from T-3-C1-2 cells, a cloned
line of Friend virus-induced erythroleukemia cells. By difference spectrophotom-
etry, the pellet was shown to contain cytochrome b5 and cytochrome P-450,
hemeproteins that have been shown to participate in electron-transport reactions
of endoplasmic reticulum and other membranous fractions of various tissues . The
pellet also possessesNADH-cytochrome c reductase activity which is inhibited by
anti-cytochrome b5 -y-globulin, indicating the presence ofcytochrome b5 reductase .
This is the first demonstration of membrane-bound forms of these redox proteins
in erythroid cells . Dimethyl sulfoxide-treated T-3-C1-2 cells were also shown to
possess membrane-bound cytochrome b5 and NADH-cytochrome c reductase
activity. We failed to detect soluble cytochrome b5 in the 105,000-g supernatant
fraction from homogenates of untreated or dimethyl sulfoxide-treated T-3-C1-2
cells . In contrast, erythrocytes obtained from mouse blood were shown to possess
soluble cytochrome b5 but no membrane-bound form of this protein. These
findings are supportive of our hypothesis that soluble cytochrome b5 of erythro-
cytes is derived from endoplasmic reticulum or some other membrane structure of
immature erythroid cells during cell maturation .
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The murine Friend virus-induced erythroleukemia
cell line has been used as a model to study eryth-
roid differentiation (10). The T-3-C 1-2 cloned line
of these erythroleukemia cells has a very low level
of spontaneous differentiation (18, 34). Upon
treatment with dimethyl sulfoxide (DMSO), how-
ever, this cell line (like other erythroleukemia
lines) undergoes changes similar to those associ-
ated with erythroid differentiation . The changes
include the appearance of erythroid membrane
antigen (17), accumulation of mRNA for globin
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synthesis (34), and synthesis of globin chains and
hemoglobin (18) .
In the present study, we have used the Friend
virus-induced erythroleukemia T-3-C1-2 line as a
model for early erythroid cells to study cytochrome
b5 , a protein found in reticulocytes and mature
erythrocytes . In non-nucleated erythroid cells, cy-
tochrome b5 (16, 31) and cytochrome b5 reductase
(16, 20, 30, 39) exist in the cytoplasm as soluble
molecules . Erythrocyte cytochrome 65 is similar to
cytochrome b5 solubilized from microsomes of the
liver. The amino acid composition ofbovine eryth-
rocyte cytochrome b5 I is in very good agreement
with a segment (residues 1-97) of bovine liver
microsomal cytochrome b5 (6) . Tryptic digestions
231of bovine erythrocyte cytochrome b5 and bovine
liver microsomal cytochrome b5 yield core heme-
peptides which are indistinguishable on the basis
of electrophoretic migration and amino acid com-
position (6, 15) .
It is our contention that, in theimmature eryth-
roid cell, cytochrome b5 is associated with mem-
branes, and that sometime during the maturation
process this hydrophobic membrane-bound pro-
tein is converted to a water-soluble molecule . In
this paper we will present evidence that cyto-
chrome b5 in an immature erythroid cell system
exists as a membrane-bound protein . Some of
these results have been presented previously in
abstract form (36) .
MATERIALS AND METHODS
Growth and Preparation of Friend
Erythroleukemia Cells
Friend virus-induced erythroleukemia cells, clonal
line T-3-C1-2, were obtained from Dr . S . Orkin of the
National Institute of Child Health and Human Devel-
opment, National Institutes of Health, Bethesda, Md .
The cells had been maintained in culture in the labora-
tory of Dr . R. Ruddon, Department of Pharmacology,
The University of Michigan. This clonal line has been
described as a "genetically homogeneous population of
erythroleukemic cells" (27) . These cells were assayed
periodically by Dr . Allen Lau, using the uridine phos-
phorylase assay (22), and were found to be free of
mycoplasma contamination (21) .
The cells were grown in suspension with RPMI-1640
powdered tissue culture medium (9 .4 g/liter) to which
NaHC03 (1 .8 g/liter), penicillin (0.07 g/liter), strepto-
mycin (0 .1 g/liter), and I N HCl (3 .4 ml/liter)had been
added . The medium was also supplemented with 10%
fetal calf serum (KC Biological, Inc., Lenexa, Kans .) .
The growth medium was sterilized by filtration through
a 0.22-[Lm Millipore filter (Millipore Corp ., Bedford,
Mass.) . All cultures were initiated at a concentration of
3 x 10" cells/ml ofmedium in a total vol of 200ml. The
cultures were maintained in one I Corning plastic flasks
(Corning Glass Works, Science Products Div., Corning,
N.Y .) . The flasks were briefly gassed with 5% C02-95%
air and incubated at 37 °C. When cells were treated with
DMSO, the cultures were initiated in the same way
except for the addition ofDMSO to a final concentration
of 1.2%. All cells were incubated for 96 h . Cells were
harvested by centrifugation at 600 g for 10 min. Pellets
were washed with 0.9%NaCl and frozen at -70°C.
Cell counts were performed in hemocytometers with
0.9% NaCl as diluent . Cell viability was determined by
Erythrosin B dye exclusion . Hemoglobin wasstained as
follows :' Immediately before use, 5.0 ml of H2O and 0.5
' This procedure suggested by Dr. S . Orkin .
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ml of 30% H202 were combined with 1.0 ml stock
benzidine solution (3% benzidine in 90% acetic acid) .
Two drops of stain were added to 0.2 ml of cell suspen-
sion . After 15 min, the number of benzidine-positive
cells were counted in a hemocytometer.
Electron Microscopy
The cells were collected by centrifugation at 600 gfor
10 min to form a pellet of - I mm thickness . To the
pellet, 3% glutaraldehyde containing 0.1 M phosphate
buffer, pH 7.2, was added . The pellet wasallowed to fix
in the solution for 30 min. The pellet was then washed
three times with 0.1 M cacodylate buffer, pH 7.3, con-
taining 0.2M sucrose . The pellet remained in this solu-
tion in the cold until it was postfixed in 2% osmium
tetroxide-0.1 M cacodylate buffer, pH 7.2, and then it
was dehydrated in a graded ethanol series . The dehy-
drated pellet was washed in propylene oxide, soaked in
propylene oxide andEpon,andthen embedded in Epon .
Sections were prepared, post-stained with uranyl acetate
(9) and lead citrate (33), and examined with an AEI
Corinth 275 electron microscope.
Preparation of a 105,000-g Pellet
A 105,000-g pellet was prepared from untreated and
DMSO-treated cells by a modification of the method of
Omura and Sato (26) . The cells were homogenized with
3 vol ofcold 0.25M sucrose containing 0.001 MEDTA,
pH 7.6, inaPotter-Elvehjem homogenizer equipped with
a Teflon pestle (E . I . DuPont de Nemours & Co ., Inc.,
Wilmington, Del.) . The homogenate was centrifuged at
12,100 g for 25 min in aSorvall RC-2B centrifuge at 0°C
(DuPont Instruments-Sorvall, DuPont Co ., Newton,
Conn .) . The precipitate was discarded and the superna-
tant fraction was centrifuged at 105,000 g for 1 h in a
Beckman L5-65 preparative ultracentrifuge (Beckman
Instruments, Inc., Spinco Div., Palo Alto, Calif.) . The
resulting pellet was then resuspended in 1.15% KCI with
aDounce homogenizer (KontesCo., Vineland,N.J .) and
recentrifuged at 105,000g for I h. The washed, 105,000-
g pellet was resuspended in 0.1M potassium phosphate,
pH 7.0 . Proteindeterminations were made by the method
of Lowry et al . using bovine serum albumin as standard
(23) .
Difference Spectra of the 105,000-g Pellet
Difference spectra of the 105,000-g pellet preparations
were measured in an Aminco Chance DW-2 spectropho-
tometer (American Instrument Co ., Travenol Laborato-
ries Inc., Silver Spring, Md .) using cuvettes of 1-cm
optical path . The pellets from either untreated orDMSO-
treated cells were placed in both thesample and reference
compartments. After recording the baseline, NADH was
added to thesample cuvetteandthe difference spectrum
wasrecorded . The amount of cytochrome b ; presentwas
calculated from the reduced minus oxidized difference
spectrum using AemM(424-409 nm) = 185 according toOmura and Sato (26) . To obtain the reduced CO-com-
plex minus reduced difference spectrum, CO was bub-
bled through the sample cuvette and then solid sodium
dithionite was added to both sample and reference cu-
vettes .Thecontentofcytochrome P-450 wasdetermined
from thereducedCO-complex minus reduced difference
spectrum usingAEmm (450-490 nm) = 91 (26).
NADH Cytochrome c Reductase Assay
The NADH cytochrome c reductase activity of the
105,000-g pellet was assayed by measuring the rate of
reduction of cytochrome c (horse heart type 111; Sigma
Chemical Co ., St . Louis, Mo.) using NADH (24) . A
value of21 .0 for the change in the millimolar extinction
coefficient at 550 nm for ferrocytochrome c was used in
the calculation of specific activity (25) . The reaction
mixture contained 0.1 M potassium phosphate buffer,
pH 7.4, 0.1 mM KCN (to inhibit contaminating mito-
chondria), 0 . l mM cytochrome c, microsomes (10 yl of
l mg/ml solution), and water to a total volof I ml. The
reaction was started by the addition ofNADH and the
absorbance changes at 550 nm were recorded at 30°C .
In experiments where anti-cytochrome b5 -y-globulinwas
added, all components (minus NADH) were pre-incu-
bated for 20 min at 30°C with the y-globulin and the
reaction was then started with the addition of NADH .
The rabbit anti-cytochrome bs -y-globulin (a generous
gift from Dr . T. Omura and Dr . G . Mannering) had
been prepared against trypsin-solubilized rat liver micro-
somal cytochrome b, which showed a single band on
acrylamide gel electrophoresis .
Isolation ofSoluble Cytochrome b5from
Mouse Erythrocytes
Soluble cytochrome b, was isolated from mouse eryth-
rocytes by a modification of theprocedure used to isolate
soluble cytochrome be from the supernatant fraction of
bovine erythrocytes (6) . The isolation procedure was
carried out at 4°C using deionized-distilled water
throughout. Mousewholeblood(Type I, fresh, in citrate)
was obtained from Pel Freez Biologicals Inc., Rogers,
Ariz. The blood was centrifuged at 3,000 g for 10 min.
The supernatant fraction and leukocytes (along with
some erythrocytes) were removed by aspiration . The
packed cells were washed in 0.9%NaCl andcentrifuged
at 3,000g for 10 min. The resulting packed erythrocytes
(4.5 ml) were then lysed with 3 vol of water . Thehemo-
lysate was stored at -70°C . Thehemolysate wasthawed,
thepH was adjusted to 6.0, and the stromal fraction was
removed by centrifugation at 12,100 g for 30 min. The
supernatant fraction was diluted with 2vol ofwater and
applied to a0.5 x 5-cm DEAE-cellulose column which
hadbeen previouslyequilibrated with 0.003Mpotassium
phosphate buffer, pH 7.2. After a wash with the same
buffer, the column was eluted sequentially with 0.01 M
KH2PO 4-0.01 M KCI, 0.05 M KH2POa, and finally 0.2
MKH 2PO4 . Absolute and difference spectra of the iso-
lated cytochrome b, were recorded with a Cary 14 spec-
trophotometer (Cary Instruments, Fairfield, N .J .) .
Attempted Isolation of Soluble Cytochrome
b5from the 105,000-g Supernatant Fraction
of T-3-CI-2 Cell Homogenate
The 105,000-g supernatant fraction of the erythroleu-
kemia cell homogenate was diluted with 3 vol of water
and then subjected to the same column chromatographic
procedure that was used for the isolation of soluble
cytochrome b, from mouse erythrocytes . Absolute and
difference spectra of the eluted fractions were recorded
with a Cary 14 spectrophotometer .
RESULTS
Morphology of Untreated and DMSO-
Treated Murine Friend Erythroleukemia
Cells, Clonal Line T-3-CI-2
Fig. I shows electron micrographs of both un-
treated and DMSO-treated T-3-CI-2 cells har-
vested after 96 h of growth . The untreated T-3-
Cl-2 cell (Fig. 1A) shows a subcellular pattern
similar to that of very early erythroid cells (proer-
ythroblast to basophilic erythroblast), as has been
previously reported (35) . The cell has a high nu-
clear-to-cytoplasmic ratio, numerous mitochon-
dria, and a very electron-dense cytoplasm due to
the presence of large numbers of ribosomes .
Rough endoplasmic reticulum is present in small
amounts.
The DMSO-treated cell (Fig . 1B) has a subcel-
lular pattern similar to that ofthe late erythroblast
cells (polychromatophilic to orthochromatophilic
erythroblast) . The cell still possesses ribosomes,
mitochondria, and small amounts of rough endo-
plasmic reticulum, but it has a lower nuclear-to-
cytoplasmic ratio. One prominent difference be-
tween the untreated and the DMSO-treated cell is
that the latter cell exhibits the presence ofcomplex
vacuolar structures containing numerous virus
particles. Also, an increase in the numbers of
budding viruses is seen. These changes are char-
acteristic of erythroleukemia cells induced to dif-
ferentiate by DMSO (11, 12, 35). Fig. 1 C shows a
portion of a DMSO-treated cell which shows sev-
eral budding viruses .
Detection ofMembrane-bound Cytochrome
b 5 and Cytochrome P-450
We obtained a 105,000-g pellet from both un-
treated and DMSO-treated erythroleukemia cells.
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Electron micrographs of T-3-C1-2 erythroleukemia cells . (A) An untreated cell after 96 h of
growth . The cell has a large nucleus (N), numerous mitochondria (M), and traces of rough endoplasmic
reticulum (arrow head) . Bar, 0.5 jLm . x 30,000 . (B)A T-3-C1-2 cell after 96 h ofDMSO treatment . The
cell retains a nucleus (N), mitochondria (M), andlow levels of rough endoplasmic reticulum (arrow head) .
Complex vacuolar structures (CVS) containing numerous virus particles are seen frequently . An increase
in the number ofbudding viruses is also seen . Bar, 0.5 jLm . x 30,000. (C)Aportion of a T-3-C 1-2 cell after
96 h ofDMSO treatment which shows several budding viruses. Bar, 0.5 fLm. x 45,000 .
The yield of protein in the 105,000-g pellet was
8.5 mg/ 10 9 cells for untreated cells and 5.0 mg/
10 9 cells forDMSO-treated cells . The visible spec-
tral properties of the 105,000-g pellet from the
erythroleukemia cells are summarized in Table 1 .
The NADH reduced minus oxidized difference
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spectrum (Fig. 2) shows absorbance maxima at
426, 526, and 559 nm . The spectrum corresponds
to that of mouse liver microsomal cytochrome 65
observed in this study and to the spectrum of
microsomal cytochrome b5 of other tissues. A sim-
ilar NADH reduced minus oxidized spectrum was005
0,04
W
Z 003
m
0 0.02
a 0 .01
0,00
- 0 .01
Comparison of Visible Spectral Properties of the 105,000-g Pelletfrom Erythroleukemia Cell with Liver
Microsomal Cytochrome b5, Liver Microsomal Cytochrome P-450, and Erythrocyte Soluble Cytochrome b5
Pellet (105,000 g) from untreated T-3-C1-2 cells
Pellet (105,000 g) from DMSO-treated T-3-C1-2 cells
Mouse liver microsomal cytochrome b 5
Mouse liver microsomal cytochrome P-450
Mouse erythrocyte soluble cytochrome b5
Reduced with sodium dithionite.
$ Reduced with NADH.
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526
559
420 , 460 500 , 540 , 580
WAVELENGTH (nm)
0 025
0.020
0015
0.005
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-0.005
TABLE I
a
FIGURE 2
￿
The NADH reducedminus oxidized differ-
ence spectrum of the 105,000-g pellet obtained from T-
3-C1-2 erythroleukemia cells . The sample and reference
cuvettes contained pellet (7 mg protein/ml) suspended
in 0.1 M phosphate buffer,pH 7 .0 . NADH wasadded to
the sample cuvette and the spectral difference measured .
Curve 1 was recorded with a full scale absorbance of
0.05 (scale on the right) . Curve 2 was recorded with a
full scale absorbance of 0.1 (scale on the left) . Curve 3
represents the recorded oxidized vs. oxidized baseline .
observed with the 105,000-g pellet from the
DMSO-treated cells .
Thereduced CO-complex minusreduced differ-
ence spectrum of the 105,000-g pellet from un-
treated T-3-CI-2 cells (Fig . 3) shows an absorb-
ance maximum at 451 nm which is typical of the
spectrum of cytochrome P-450, the CO-inhibited
hydroxylase of microsomes . The reduced CO-
complexminus reduced difference spectrum of the
pellet from the DMSO-treated cells corresponded
to that of carbonmonoxyhemoglobin minusdeox-
yhemoglobin . This indicates that the pellet had
not been washed completely free of the hemoglo-
bin synthesized by T-3-C1-2 cells as a response to
theDMSO treatment . No peak or shoulder at 450
nm could be seen . However, we cannot determine
from this spectrum whethercytochrome P-450was
0.05
W 0,04
Z
m 0.03
0
0.02
m
0.01
0.00
Absorbance maxima
Reduced CO-complex mi-
Reduced minus oxidized
￿
nus reduced'
424,525,558*
nm
426, 526, 559$
￿
451
427, 526, 559$
￿
419, 535, 571
426,528,559$ none
- 451
absent in the 105,000-g pellet of DMSO-treated
cells or whether the spectrum of cytochrome P-450
was masked by the contaminating hemoglobin .
The quantitation of cytochrome bs and cyto-
chrome P-450 in these cells is summarized in Table
II. Theamountsofcytochrome b5 in theuntreated
and DMSO-treated cells are similar (0.014 and
0.016 nmol/mg protein, respectively) . These
amounts (expressed either on the basis of number
ofcells or milligrams ofpelleted protein) aresmall
compared to the amount of microsomal cyto-
chrome b5 in mouse liver . The amount of mem-
brane-bound cytochrome P-450 in the erythroleu-
kemia cell is likewise small relative to the amount
of microsomal cytochrome P-450 in the liver cell .
The ratio of cytochrome b5 to cytochrome P-450
in erythroleukemia cells is comparable to that of
mouse liver microsomes.
420 460 500 540 580
WAVELENGTH (nm)
FIGURE 3 The reduced CO-complex minus reduced
difference spectrum ofthe 105,000-g pellet obtained from
untreated T-3-C1-2 erythroleukemia cells. The sample
and reference cuvettes contained pellet (7 mg protein/
ml) suspended in 0.1 M phosphate buffer, pH 7.0. Car-
bon monoxide was bubbled through the sample cuvette
and then sodium dithionite was added to both sample
and reference cuvettes .
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Amounts ofMembrane-Bound Redox Proteins in Mouse Erythroleukemia Cells
Evidencefor Membrane-bound Cytochrome
b5 Reductase
The 105,000-g pellets from both untreated and
DMSO-treated cells were shown to possess
NADH-cytochrome c reductase activity (Table II) .
Strittmatter and Velick (38) have shown that in
liver microsomes this activity is dependent upon
both cytochrome b 5 reductase and cytochrome b5,
andthus canbe used as evidence that both proteins
are present. Further evidence for the presence of
cytochrome b5 in the pellets from untreated and
DMSO-treated erythroleukemia cells was pro-
vided by demonstration of inhibition of the
NADH-cytochrome c reductase activities with
anti-cytochrome b5 y-globulin (Table II) . Approx .
80% inhibition of the reductase activity of these
pellets was observed when 40 mg of anti-cyto-
chrome b 5 immunoglobulin were used/mg of pro-
tein . At this concentration the same immunoglob-
ulin preparation showed 80% inhibition of the
reductase activity using solubilized liver micro-
somal proteins.'
Personal communication from Dr. S. Kuwahara and
Dr . R. Schwen of the laboratory of Dr . G. Mannering.
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From the unpublished data of Dr . Kostas Vatsis, Department of Biochemistry, The University of Michigan . The
values per 109 cells were calculated usingthevalue of 15 .9 mg microsomal protein/gofliverandthe reported value
of 1 .7 X 108 hepatocytes/g of liver (40) .
Cytosolic Cytochrome b5: Its Presence in
Mouse Erythrocytes and Its Absence in
Mouse Erythroleukemia Cells
Solublecytochrome b 5 was detected and isolated
for the first time from mouse erythrocytes . Fig . 4
shows the DEAE-cellulose elution profile for a
preparation of soluble cytochrome b5derivedfrom
4.5 ml of packed erythrocytes from mouse blood .
The oxidized, reduced, and reduced minus oxi-
dized spectra are similar to the spectra of soluble
cytochrome b5 from human, bovine, and rabbit
erythrocytes (6, 31) . The reduced minus oxidized
difference spectrum (Fig . 5) shows absorbance
maxima at 424, 525, and 558 nm . The amount of
soluble cytochrome b5 calculated from this spec-
trum was 0.87 nmol/ml of packed erythrocytes or
0.04 nmol/ 109 erythrocytes.
When this procedure was carried out on the
105,000-gsupernatant fraction from homogenates
of untreated and DMSO-treated erythroleukemia
cells, no soluble cytochrome b5 was detected . This
finding indicates an absence or very low levels of
cytochrome b5 in the cytosol of these cells even
afterDMSO treatment . Oxyhemoglobin was spec-
trally identified in the initial fractions from
Source
Protein (units)
Pellet from
unlreated T-
3-CI-2 cells
Pellet from
DMSO-
treated T-3-
CI-2 cells
Mouse liver
microsomes'
Mouse eryth-
rocytes
Total protein 8.5 5.0 93 .5 none
(mg/109 cells)
Cytochrome 65
(nmol/109 cells) 0.12 0.08 50 .5 0.04
(nmol/mg protein) 0.014 0.016 0.54 -
Cytochrome P-450
(nmol/ 109 cells) 0.22 - 150 none
(nmol/mg protein) 0.025 - 1 .60 none
NADH-cytochrome c reductase activity
(umol/min/109 cells) 0.70 0.75 97
(Pmol/min/mg protein) 0.082 0.15 1 .04
(pmol/min/109 cells in the presence of anti-cytochrome 0.16 0.15 -
b5 y-globulin)
(lumol/min/mg protein in the presence ofanti-cytochrome 0.019 0.029
b5 y-globulin)W
z a
0 0
m
a
0 .8
0 .6
0 .4
0 .2
I 3 5 7 9 II
FRACTION NUMBER
FIGURE 4
￿
Partial purification of mouse erythrocyte cy-
tochrome b, by chromatography on DEAE-cellulose .
The diluted, stroma-free mouse erythrocyte hemolysate
was applied to a 0.5 x 5-cm DEAE-cellulose column,
and the column was then eluted sequentially with 10
mM KH 2PO4-10mM KCI, 50mM KH2PO4 , and 0.2M
KH 2PO4 as described in the text . The arrow on the left
denotes the beginning of the 50 mM KH2PO 4 wash and
the arrowon the right the beginning of the 0.2 KH2PO4
wash .
w
z
0
m a
0.07
006
005
004
003
0.02
0.01
0,00
-0 .01
DISCUSSION
FIGURE 5 Reduced minus oxidized difference spec-
trum of mouse erythrocyte cytochrome b5 . Fractions 8,
9, and 10 from the DEAE-cellulose column (Fig. 4) were
pooled and added to the sample and reference cuvettes.
The material in the sample cuvette was reduced by the
addition ofsodium dithionite .
DEAE-cellulose chromatography of the 105,000-g
supernatant fraction of homogenates from
DMSO-treated T-3-CI-2 cells. This fording sug-
gests that, in theerythroleukemia cell, hemoglobin
is present in its ferrous form.
We have isolated a 105,000-g pellet from Friend
virus-induced erythroleukemia cells and have
demonstrated that the pellet contains cytochrome
bs, cytochrome P-450, and NADH-cytochrome b5
reductase activity . This is the first report of the
presence of membrane-bound forms of these pro-
teins in erythroid cells . The levels ofthese proteins
in erythroleukemia cells are low . Nonetheless,
there is no doubt that they arose from these cells,
because there were no suggestions that contami-
nating cells were present in this culture .
Cytochrome b, cytochrome P-450, and cyto-
chrome b, ", reductase have been shown to be major
constituents ofmicrosomes from kidney, lung, and
other tissues (13) . Our detection of these proteins
in the 105,000-g pellet might suggest that we have
isolated microsomes from erythroleukemia cells .
The small amounts of these membrane-bound re-
dox proteins in erythroleukemia cells, relative to
hepatocytes, wouldbe in keeping with the relative
amounts of endoplasmic reticulum which can be
observed by electron microscopy within these cells .
However, our data do not allow us to establish
whether these redox proteins are derived from
endoplasmic reticulum rather than from contami-
nating mitochondrial, nuclear, or other membrane
fractions . Both erythroleukemia cells and normal
erythroid cells, at various stages of maturation,
have been shown by electron microscopy to pos-
sess large nuclei and numerous mitochondria, in
addition to small amounts of endoplasmic reticu-
lum (1, 28, 35) . Peroxisomal and outer mitochon-
dria) membranes (but not inner mitochondrial
membranes) of rat liver have been shown to pos-
sess cytochrome b5 (7, 32, 37), and mitochondria
from adrenal glands contain substantial amounts
of cytochrome P-450 (4) . Moreover, cytochrome
P-450, NADPH-cytochrome c reductase activity,
cytochrome b5, NADH-cytochrome c reductase
activity, or combinations of these redox proteins
have been detected in nuclear membrane prepa-
rations from the livers of a variety ofspecies (2, 8,
19,41) .
In this paper, we also report the isolation of
soluble cytochrome b5 from the cytoplasmic frac-
tion ofmouse erythrocytes . Solublecytochrome b5
hadbeen isolated previously from beef(6), human
(14, 16, 31), rabbit (31), and pork (5) erythrocytes.
In contrast to the detection ofsolublecytochrome
b5 in the mature erythrocytes of the mouse, no
soluble cytochrome b5 could be detected in the
cytoplasmic fraction of mouse erythroleukemia
cells .
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serves as a model for early immature cells of the
erythroid series. Morphologically, this cell has
many of the characteristics of immature erythro-
blasts . Approx . 1% of the erythroleukemia cells
spontaneously differentiate to the level of poly-
chromatophilic and orthochromatophilic erythro-
blasts and synthesize hemoglobin (11, 12) . Upon
treatment with DMSO, Friend virus-transformed
cells exhibit changes that are analogous to those
seen in the differentiation of normal erythrocyte
precursors . The polychromatophilic- and ortho-
chromatophilic-like cells that result from DMSO
stimulation (35) develop erythrocyte membrane
antigen (17), accumulate mRNA for globin syn-
thesis (34), and synthesize globin chains indistin-
guishable from those of the adult mouse (3, 29).
It is our contention that the soluble cytochrome
b 5 and cytochrome b 5 reductase present in the
cytoplasm ofmature erythrocytes arederived from
membraneous structures (endoplasmic reticulum,
mitochondria, or nuclei) of immature erythroid
cells by proteolysis during the maturation process .
Theendoplasmic reticulum and nuclei, along with
most oftheother subcellular organelles (excluding
mitochondria), have disappeared from the cell by
the late orthochromatophilic erythroblast or retic-
ulocyte stage . Because the erythroleukemia cell is
a model for a normal immature erythroid cell, our
demonstration of membrane-bound cytochrome
b5 butno soluble cytochrome b5 in the erythroleu-
kemia cell suggests that only particulate cyto-
chrome b5 is present in normal, early immature,
erythroid cells . The finding that the amount of
membrane-bound cytochrome b5present in mouse
erythroleukemia cells is greater than the amount
of soluble cytochrome b 5 present in the cytoplasm
of mouse erythrocytes is compatible with mem-
brane structures being the origin of the soluble
cytochrome b5 .
As has been reported by other workers, we
found that DMSO caused the erythroleukemia
cells to differentiate, as evidenced by positive ben-
zidine staining ofthe cells, the red colorofthe cell
pellet, the spectral demonstration of hemoglobin,
and the orthochromatophilic-like morphological
features of the cells . Electron microscopy of these
DMSO-treated cells revealed small amounts of
endoplasmic reticulum to be still present. Cyto-
chrome b5 and cytochrome b 5 reductase were de-
tected in the 105,000-g pellets of the DMSO-
treated cells, and no cytochrome b5 was detected
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in the 105,000-g supernatant fraction. Apparently,
DMSO-induced differentiation of erythroleuke-
mia cells to the polychromatophilic or orthochro-
matophilic erythroblast stagedoes not result in the
solubilization ofcytochrome b5 . The exact stage at
which solubilization of membrane-bound cyto-
chrome 115 occurs during normal erythroid matu-
ration remains to be elucidated .
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